{"text": "Order of the Vice-President of the Court of 26 February 2020 — Medac Gesellschaft für klinische Spezialpräparate v Commission", "label": [[13, 27, "PROFESSION"], [31, 40, "ORG"], [44, 60, "DATE"], [63, 112, "ORG"], [115, 125, "ORG"]]}
{"text": "(Case C‑832/19 P(R))", "label": []}
{"text": "(Appeal — Order for interim measures — Medicinal products for human use — Application for marketing authorisation for an orphan medicinal product —Commission decision to remove a medicinal product from the Register of Orphan Medicinal Products — Urgency — Serious and irreparable damage — None)", "label": [[206, 243, "ORG"]]}
{"text": "Appeal — Grounds — Incorrect assessment of the facts and evidence — Inadmissibility — Review by the Court of the General Court’s findings with regard to national law — Possible only where the clear sense of the evidence has been distorted", "label": [[96, 105, "ORG"], [109, 128, "ORG"]]}
{"text": "(Art. 256(1), second para., TFEU; Statue of the Court of Justice, Art. 58, first para.)", "label": [[44, 64, "ORG"]]}
{"text": "(see para. 40, 41)", "label": []}
{"text": "Operative part", "label": []}
{"text": "1. The appeal is dismisssed.", "label": []}
{"text": "2. Medac Gesellschaft für klinische Spezialpräparate mbH is ordered to pay the costs.", "label": [[3, 56, "ORG"]]}
